Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Alumis Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

52W Range

67thpctl

Volume

0.54×avg

Market Cap

2.76BUSD

P/E Ratio

-5.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Alumis Inc.

ALMSNASDAQ·USD·Closed

Alumis Inc.

ALMSNASDAQ·USD·Closed

$22.38

−3.58%

$22.38

−$0.83 (3.58%)

52W Range

67thpctl

Volume

0.54×avg

Mkt Cap

2.76BUSD

P/E

-5.9TTM

Div Yield

–ann

ALMS: Alumis Inc. Stock Analysis | finqOS